Nuvation Bio INC. (NUVB) — 8-K Filings

All 8-K filings from Nuvation Bio INC.. Browse 20 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (20)

8-K Filing — Nov 26, 2025
Nuvation Bio Inc. Files 8-K with Financial Updates — Nov 17, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on November 17, 2025, reporting on various events and financial statements. The company, formerly Panacea Acquisition Corp. until
Nuvation Bio Files 8-K on Operations and Financials — Aug 7, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements
Nuvation Bio Inc. Files 8-K — Jun 11, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on June 11, 2025, reporting on other events and financial statements. The company, formerly Panacea Acquisition Corp., is incorpo
Nuvation Bio Inc. Files 8-K on Shareholder Vote Matters — May 23, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on May 23, 2025, reporting on a submission of matters to a vote of security holders that occurred on May 21, 2025. The company, f
Nuvation Bio Files 8-K on Financials — May 7, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and
Nuvation Bio Enters Material Definitive Agreement — Mar 25, 2025 Risk: medium
Nuvation Bio Inc. entered into a material definitive agreement on March 21, 2025. The company, formerly known as Panacea Acquisition Corp., is incorporated in D
Nuvation Bio Files 8-K on Financials — Mar 6, 2025 Risk: low
Nuvation Bio Inc. filed an 8-K on March 6, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements a
Nuvation Bio Inc. Enters Material Definitive Agreement — Mar 5, 2025 Risk: medium
On March 3, 2025, Nuvation Bio Inc. entered into a material definitive agreement. The company, formerly known as Panacea Acquisition Corp. until April 30, 2020,
Nuvation Bio Inc. Enters Material Agreement, Incurs Financial Obligation — Mar 4, 2025 Risk: medium
On March 3, 2025, Nuvation Bio Inc. entered into a material definitive agreement and created a direct financial obligation. The company, formerly known as Panac
Nuvation Bio Inc. Reports Officer and Director Changes — Feb 12, 2025 Risk: medium
Nuvation Bio Inc. filed an 8-K on February 12, 2025, reporting changes effective February 11, 2025. The filing pertains to the departure of directors or certain
Nuvation Bio Inc. Files 8-K on Financials — Nov 6, 2024 Risk: low
Nuvation Bio Inc. filed an 8-K on November 6, 2024, reporting on its results of operations and financial condition. The filing indicates the company's principal
Nuvation Bio Inc. Reports Director Changes and Compensation Updates — Oct 7, 2024 Risk: medium
Nuvation Bio Inc. announced on October 7, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure of
Nuvation Bio Inc. Files 8-K on Shareholder Votes and Events — Sep 5, 2024 Risk: low
Nuvation Bio Inc. filed an 8-K on September 5, 2024, reporting on matters submitted to a vote of security holders and other events that occurred on September 3,
Nuvation Bio Files 8-K on Operations and Financials — Aug 5, 2024 Risk: low
Nuvation Bio Inc. filed an 8-K on August 5, 2024, reporting on its results of operations and financial condition. The filing indicates the company's incorporati
Nuvation Bio Inc. Files 8-K on Operations — May 14, 2024 Risk: low
Nuvation Bio Inc. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition. The filing indicates the company's principal exe
Nuvation Bio Completes SPAC Merger, Raises $100M — Apr 10, 2024 Risk: medium
Nuvation Bio Inc. announced on April 9, 2024, the completion of its business combination with Anzu Special Acquisition Corp I. This transaction resulted in the
Nuvation Bio Inc. Files 8-K: Material Agreement & Equity Sales — Mar 25, 2024 Risk: medium
Nuvation Bio Inc. announced on March 24, 2024, that it entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity sec
Nuvation Bio Files 8-K on Financials — Feb 29, 2024 Risk: low
Nuvation Bio Inc. filed an 8-K on February 29, 2024, reporting on its results of operations and financial condition. The filing includes financial statements an
Nuvation Bio Relocates HQ to New York City — Jan 8, 2024
Nuvation Bio Inc. filed an 8-K on January 8, 2024, to report a change in its principal executive offices from 357 Tehama Street, San Francisco, CA 94103 to 1500

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX